Atorvastatin inhibits glioma glycolysis and immune escape by modulating the miR-125a-5p/TXLNA axis
ATOR blocks glioma progression by modulating the miR-125a-5p/TXLNA axis, further demonstrating that ATOR provides an effective therapeutic target for the treatment of glioma.
Authors
- TangYue Li
- Ying-Chun Yin
- Tao Zhou (ORCID: https://orcid.org/0000-0002-5345-8264)
- Xueying Sun (ORCID: https://orcid.org/0000-0002-8065-8747)
- Heping Jiang
- Kang Gao (ORCID: https://orcid.org/0000-0003-2551-1715)
Institutions
- Central Hospital of Zibo (CN)
Publication Details
- Journal
- Hereditas
- Published
- 2024-12-26
- DOI
- https://doi.org/10.1186/s41065-024-00349-5
- Citations
- 4
- Primary Topic
- MicroRNA in disease regulation
- Type
- article
- Field-Weighted Citation Impact
- 1.14